MLchartDataset catalogue

allogeneic CD8+ leukemia-associated antigens specific T cells NEXI-001

Term · Oncology and biomedicine · MLC-T-ONC-009859

A preparation of allogeneic CD8+ T cells targeting multiple undisclosed leukemia-associated antigens, with potential immunomodulating and antineoplastic activities. Following peripheral blood mononuclear cell (PBMC) collection from the original stem cell donor and ex vivo priming and expansion, the allogeneic CD8+ leukemia-associated antigens specific T cells NEXI-001 are re-introduced into the leukemia patient, where they target and kill tumor cells expressing these leukemia-associated antigens.

Table 1. Record
IdentifierMLC-T-ONC-009859
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-009859",
  "term": "allogeneic CD8+ leukemia-associated antigens specific T cells NEXI-001",
  "field": "Oncology and biomedicine",
  "definition": "A preparation of allogeneic CD8+ T cells targeting multiple undisclosed leukemia-associated antigens, with potential immunomodulating and antineoplastic activities. Following peripheral blood mononuclear cell (PBMC) collection from the original stem cell donor and ex vivo priming and expansion, the allogeneic CD8+ leukemia-associated antigens specific T cells NEXI-001 are re-introduced into the leukemia patient, where they target and kill tumor cells expressing these leukemia-associated antigens.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/allogeneic-cd8-plus-leukemia-associated-antigens-specific-t-cells-nexi-001/"
}

Record 745 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.